Featured Publications
The Alzheimer's disease-linked protease BACE2 cleaves VEGFR3 and modulates its signaling.
The journal of clinical investigation 134(16), e170550 (2024) [10.1172/JCI170550]
Files Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
The Alzheimer’s disease-linked protease BACE1 modulates neuronal IL-6 signaling through shedding of the receptor gp130
Molecular neurodegeneration 18(1), 13 (2023) [10.1186/s13024-023-00596-6]
Files Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for γ-secretase activity.
EMBO molecular medicine 14(10), e16084 (2022) [10.15252/emmm.202216084]
Files Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
The case for low-level BACE1 inhibition for the prevention of Alzheimer disease.
Nature reviews / Neurology 17(11), 703 - 714 (2021) [10.1038/s41582-021-00545-1]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
An optimized quantitative proteomics method establishes the cell type-resolved mouse brain secretome.
The EMBO journal 39(20), e105693 (2020) [10.15252/embj.2020105693]
Files Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Pathology-linked protease caught in action.
Science / Science now 363(6428), 690-691 (2019) [10.1126/science.aaw5547]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments.
The EMBO journal 37(15), e99456 (2018) [10.15252/embj.201899456]
Files Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS